Merger Arbitrage Mondays – Seven Deals Close With Few New Ones In Sight

Merger activity decreased last week with one new deal announced and seven deals closing. You can find all the active deals listed below in our Merger Arbitrage Tool (MAT) that automatically updates itself during market hours.

There were no new deals announced in the Deals in the Works section.

Deal Statistics:

New Deals:

1. The acquisition of Ra Pharmaceuticals (RARX) by UCB for $2.1 billion or $48.00 per share in cash.

Only plus or premium subscribers can access this post. Subscribe today.